IRON CHELATOR MEDICATIONS USED BY PATIENTS WITH BETA THALASSEMIA MAJOR, THALASSEMIA RESEARCH CENTER, IRAN, 2015

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KOSARIAN MEHRNOOSH; ASGHARIAN AILI ALI

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: (JOURNAL OF HEALTH BREEZE) FAMILY HEALTH Year:2016 | Volume:5 | Issue:2 (18) Page(s): 41-45

Download Full-Text

Persian Verion

View:

4,246

Download:

Cites:

Information Journal Paper

Title

IRON CHELATOR MEDICATIONS USED BY PATIENTS WITH BETA THALASSEMIA MAJOR, THALASSEMIA RESEARCH CENTER, IRAN, 2015

Author(s)

KOSARIAN MEHRNOOSH | ASGHARIAN AILI ALI | Issue Writer Certificate

Keywords

BETA THALASSEMIA MAJORQ1

IRON CHELATORQ1

TREATMENTQ1

COMPLIANCEQ1

DESFERRIOXAMINEQ1

DEFERIPRONEQ1

DEFERAZIROXQ1

Abstract

Background and Objective: Selection of IRON CHELATOR medication for thalassemic patients depends on clinical and laboratory characteristics such as age, serum ferritin and severity of different organ damage. Patient choice is also important because the COMPLIANCE to TREATMENT is essential. Policy makers should decide to import brands versus to facilitate making medications in the country. Insurance companies also should decide for coverage the costs. In this paper we report the current situation of IRON CHELATOR usage for patients with BETA THALASSEMIA MAJOR in our center.Method: We reviewed data the medical records of patients in November 2015.Results: There were 463 patients on IRON CHELATOR medications. Three hundred and thirty patients (71.2%) had regular blood transfusions and reminders were not on regular blood transfusion. Two hundred and fifty one (54%), and 212 (46%) were using one or two IRON CHELATORs, respectively. Two hundred and two (44%) patients were using a combination of a parenteral and one oral medication. Sixty seven (14%) patients were using only parenteral IRON CHELATOR. The most common used medication was Osveral (made in Iran by Osveh Pharmaceutical) in about one third of patients. All non-transfusion dependent patients were using Osveral. The parenteral medication (Desferrioxamine) was distributed in two brands. One imported brand as Desferal (Novartis) and the other as Desfonak (made in Iran by Ronak Daru).Deferiprone (made in Avesina, Iran) was used in combination with DESFERRIOXAMINE in 141 patients and as the only TREATMENT in 11 patients.Conclusion: Availability of different types of medications makes the opportunity to select the best protocol for patients.

Cites

No record.

References

No record.

Cite

APA: Copy

KOSARIAN, MEHRNOOSH, & ASGHARIAN, AILI ALI. (2016). IRON CHELATOR MEDICATIONS USED BY PATIENTS WITH BETA THALASSEMIA MAJOR, THALASSEMIA RESEARCH CENTER, IRAN, 2015. (JOURNAL OF HEALTH BREEZE) FAMILY HEALTH, 5(2 (18) ), 41-45. SID. https://sid.ir/paper/128351/en

Vancouver: Copy

KOSARIAN MEHRNOOSH, ASGHARIAN AILI ALI. IRON CHELATOR MEDICATIONS USED BY PATIENTS WITH BETA THALASSEMIA MAJOR, THALASSEMIA RESEARCH CENTER, IRAN, 2015. (JOURNAL OF HEALTH BREEZE) FAMILY HEALTH[Internet]. 2016;5(2 (18) ):41-45. Available from: https://sid.ir/paper/128351/en

IEEE: Copy

MEHRNOOSH KOSARIAN, and AILI ALI ASGHARIAN, “IRON CHELATOR MEDICATIONS USED BY PATIENTS WITH BETA THALASSEMIA MAJOR, THALASSEMIA RESEARCH CENTER, IRAN, 2015,” (JOURNAL OF HEALTH BREEZE) FAMILY HEALTH, vol. 5, no. 2 (18) , pp. 41–45, 2016, [Online]. Available: https://sid.ir/paper/128351/en

Related Journal Papers